对肝细胞癌的创新方法:诊断突破,生物标志物集成和人工智能
Evangelos Koustas1, Eleni-Myrto Trifylli2, Panagiotis Sarantis2,3
1Oncology Department, General Hospital Evangelismos, Ipsilantou 45-47, 10676 Athens, Greece.
Biomedicines
|October 29, 2025
概括
原发性肝癌是全球主要的健康问题. 本研究研究了影响其发生率和结果的关键因素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 原发性肝癌是全球第五个最常见的恶性瘤.
- 它是全球癌症相关死亡的第二大原因.
- 在不同地区的肝癌负担存在显著差异.
研究的目的:
- 分析原发性肝癌的全球流行病学.
- 确定与肝癌相关的风险因素和趋势.
- 评估当前的管理策略和生存率.
主要方法:
- 全球癌症登记册和流行病学研究的系统审查.
- 对发病率,死亡率和存活率数据的统计分析.
- 风险因素的元分析,包括病毒性肝炎,酒精和代谢综合征.
主要成果:
- 肝细胞癌 (HCC) 构成了大多数原发性肝癌.
- 乙型肝炎和C型肝炎感染仍然是流行地区的主导风险因素.
- 观察到与非酒精性脂肪性肝病 (NAFLD) 相关的HCC.的增加趋势.
- 根据诊断阶段和地理位置,生存率有很大差异.
结论:
- 原发性肝癌是一个重大的全球健康挑战,需要有针对性的预防和早期检测策略.
- 解决病毒性肝炎和代谢性疾病对于减少肝癌负担至关重要.
- 对新型治疗方法的进一步研究是有必要的,以改善患者的治疗结果.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.7K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
